These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 24980827)
1. Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration. Hailer A; Grunewald TG; Orth M; Reiss C; Kneitz B; Spahn M; Butt E Oncotarget; 2014 Jun; 5(12):4144-4153. PubMed ID: 24980827 [TBL] [Abstract][Full Text] [Related]
2. Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer. Nishikawa R; Goto Y; Sakamoto S; Chiyomaru T; Enokida H; Kojima S; Kinoshita T; Yamamoto N; Nakagawa M; Naya Y; Ichikawa T; Seki N Cancer Sci; 2014 Jul; 105(7):802-11. PubMed ID: 24815849 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA LINC01207 promotes prostate cancer progression by downregulating microRNA-1972 and upregulating LIM and SH3 protein 1. Wang S; Qiu J; Wang L; Wu Z; Zhang X; Li Q; Jiang F IUBMB Life; 2020 Sep; 72(9):1960-1975. PubMed ID: 32726517 [TBL] [Abstract][Full Text] [Related]
4. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer. Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding DANCR targets miR-185-5p to upregulate LIM and SH3 protein 1 promoting prostate cancer via the FAK/PI3K/AKT/GSK3β/snail pathway. Sun W; Zu S; Shao G; Wang W; Gong F J Gene Med; 2021 Jul; 23(7):e3344. PubMed ID: 33885171 [TBL] [Abstract][Full Text] [Related]
6. Regulation of matrix metalloproteinases (MMPs) expression and secretion in MDA-MB-231 breast cancer cells by LIM and SH3 protein 1 (LASP1). Endres M; Kneitz S; Orth MF; Perera RK; Zernecke A; Butt E Oncotarget; 2016 Sep; 7(39):64244-64259. PubMed ID: 27588391 [TBL] [Abstract][Full Text] [Related]
7. Identification of miR-1-3p, miR-143-3p and miR-145-5p association with bone metastasis of Gleason 3+4 prostate cancer and involvement of LASP1 regulation. Guo H; Zhao J; Li X; Sun F; Qin Y; Yang X; Xiong X; Yin Q; Wang X; Gao L; Jiao M; Hu J; Han B Mol Cell Probes; 2023 Apr; 68():101901. PubMed ID: 36791996 [TBL] [Abstract][Full Text] [Related]
8. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis. Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079 [TBL] [Abstract][Full Text] [Related]
9. Circ_0023028 contributes to the progression of laryngeal squamous cell carcinoma by upregulating LASP1 through miR-486-3p. Zheng Y; Duan L; Yang Y; Luo D; Yan B Mol Cell Biochem; 2021 Aug; 476(8):2951-2961. PubMed ID: 33755879 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-218 inhibits the proliferation, migration, and invasion and promotes apoptosis of gastric cancer cells by targeting LASP1. Wang LL; Wang L; Wang XY; Shang D; Yin SJ; Sun LL; Ji HB Tumour Biol; 2016 Nov; 37(11):15241-15252. PubMed ID: 27696291 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells. Wang C; Zheng X; Shen C; Shi Y J Exp Clin Cancer Res; 2012 Jun; 31(1):58. PubMed ID: 22713668 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-133a acts as a tumour suppressor in breast cancer through targeting LASP1. Sui Y; Zhang X; Yang H; Wei W; Wang M Oncol Rep; 2018 Feb; 39(2):473-482. PubMed ID: 29207145 [TBL] [Abstract][Full Text] [Related]
13. The tumor-suppressive function of miR-1 by targeting LASP1 and TAGLN2 in esophageal squamous cell carcinoma. Du YY; Zhao LM; Chen L; Sang MX; Li J; Ma M; Liu JF J Gastroenterol Hepatol; 2016 Feb; 31(2):384-93. PubMed ID: 26414725 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-133b Inhibits Proliferation, Cellular Migration, and Invasion via Targeting LASP1 in Hepatocarcinoma Cells. Li H; Xiang Z; Liu Y; Xu B; Tang J Oncol Res; 2017 Sep; 25(8):1269-1282. PubMed ID: 28117027 [TBL] [Abstract][Full Text] [Related]
15. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway. Wang H; An H; Wang B; Liao Q; Li W; Jin X; Cui S; Zhang Y; Ding Y; Zhao L Eur J Cancer; 2013 Dec; 49(18):3924-35. PubMed ID: 23968734 [TBL] [Abstract][Full Text] [Related]
16. MiR-665 suppresses the progression of diffuse large B cell lymphoma (DLBCL) through targeting LIM and SH3 protein 1 (LASP1). Wang Y; Guo D; Li B; Wang Y; Wang B; Wang Z; Wang M; Teng Q Leuk Res; 2022 Jan; 112():106769. PubMed ID: 34875555 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-326 inhibits cell proliferation and invasion, activating apoptosis in hepatocellular carcinoma by directly targeting LIM and SH3 protein 1. Hu S; Ran Y; Chen W; Zhang Y; Xu Y Oncol Rep; 2017 Sep; 38(3):1569-1578. PubMed ID: 28713953 [TBL] [Abstract][Full Text] [Related]
18. COPS5 and LASP1 synergistically interact to downregulate 14-3-3σ expression and promote colorectal cancer progression via activating PI3K/AKT pathway. Zhou R; Shao Z; Liu J; Zhan W; Gao Q; Pan Z; Wu L; Xu L; Ding Y; Zhao L Int J Cancer; 2018 May; 142(9):1853-1864. PubMed ID: 29226323 [TBL] [Abstract][Full Text] [Related]
19. Circ_0075804 Regulates the Expression of LASP1 by Targeting miR-1287-5p and Thus Affects the Biological Process of Retinoblastoma. Han Q; Ma L; Shao L; Wang H; Feng M Curr Eye Res; 2022 Jul; 47(7):1077-1086. PubMed ID: 35285372 [TBL] [Abstract][Full Text] [Related]
20. LASP1 in Tumor and Tumor Microenvironment. Hu Z; Wang X; Cui Y; Li C; Wang S Curr Mol Med; 2017; 17(8):541-548. PubMed ID: 29473505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]